Brígida R Pinho

5PUBLICATIONS
9CO-AUTHORS
Metabolic medicineNeurology and neuromuscular diseasesSurface water quality processes and contaminated sediment assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
Mitophagy: an emerging therapeutic target in mitochondrial diseases.

|May 21, 2026
Inhibition of the mitochondrial pyruvate carrier attenuates the integrated stress response activation in a cellular model of Huntington's disease.

|Feb 13, 2026
The PERK inhibitor GSK2606414 evokes developmental defects in zebrafish consistent with Wolcott-Rallison syndrome phenotypes.

Liliana M Almeida, Leonor Pereira Lima, Nuno A S Oliveira

|Apr 25, 2024
PERK inhibition with GSK2606414 in zebrafish evokes developmental defects consistent with Wolcott-Rallison syndrome phenotypes.

Liliana M Almeida, Leonor Pereira Lima, Nuno A S Oliveira

|Apr 27, 2022
The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases.

Liliana M Almeida, Brígida R Pinho, Michael R Duchen

Pageof 1

Frequent Collaborators

5 joint publications

Jorge M A Oliveira

4 joint publications

Liliana M Almeida

2 joint publications

Michael R Duchen

2 joint publications

Leonor Pereira Lima